MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ALVR
  4. News
ALVR
Quote
Short
News
Articles
Message Board

AlloVir Inc. (NASDAQ : ALVR ) News

News Releases

ALVR News Releases
ALVR : NASDAQ
GlobeNewswire
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
ALVR : NASDAQ
GlobeNewswire
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
ALVR : NASDAQ
GlobeNewswire
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
ALVR : NASDAQ
GlobeNewswire
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
ALVR : NASDAQ
GlobeNewswire
Kalaris Reports Third Quarter 2025 Financial Results and Provides Business Updates
ALVR : NASDAQ
GlobeNewswire
Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer
ALVR : NASDAQ
GlobeNewswire
Kalaris to Present at Stifel 2025 Annual Healthcare Conference
ALVR : NASDAQ
GlobeNewswire
UPDATE - Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
ALVR : NASDAQ
GlobeNewswire
Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
ALVR : NASDAQ
GlobeNewswire
Kalaris Reports Second Quarter 2025 Financial Results and Provides Business Updates
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.